$CVM Thank you for the go-ahead from FDA for the confirmatory trial. We already know how the selected patients did in the completed study. 73% survival with Multikine vs 45% without Multikine. We can help a lot of patients. I believe! So I bought more stock.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.